BIO-key International will host its Q4 2024 investor call on March 27th at 10 a.m. ET, following a results release before the market opening. The call will be led by CEO Mike DePasquale and CFO Cecilia Welch. Various access options for the call are provided, emphasizing their innovative IAM solutions for security.
BIO-key International, Inc. (NASDAQ: BKYI), a provider of Identity and Access Management (IAM) and biometric solutions, will conduct its Q4 2024 investor call on March 27th at 10 a.m. ET. The company plans to release its financial results prior to market opening on the same day, with CEO Mike DePasquale and CFO Cecilia Welch leading the call and Q&A session.
Conference Call Details:
– Date/Time: Thursday, March 27th at 10 a.m. ET
– Dial In Numbers: 1-877-418-5460 (U.S.); 1-412-717-9594 (International)
– Live Webcast/Replay: Available for 3 months via the provided Webcast link.
– Audio Replay: 1-877-344-7529 (U.S.); 1-412-317-0088 (International), Access Code: 6747311.
About BIO-key International, Inc.:
BIO-key is transforming authentication and cybersecurity through its biometric-focused IAM software, protecting over 40 million users. The company offers various authentication options, including phoneless, tokenless, and passwordless solutions, suited for diverse applications. Their PortalGuard IAM solution can be deployed either hosted or on-premise, providing secure, convenient access to sensitive data and resources.
BIO-key International will hold a vital Q4 2024 investor call on March 27th, with significant insights expected from its leadership. The company’s innovative IAM solutions reflect its commitment to biometric security. Investors can access the call via phone or webcast, underlining BIO-key’s proactive communication strategy with stakeholders.
Original Source: www.globenewswire.com
